Ciudad Autonoma de Buenos Aires, Argentina

Camila Scorticati

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Camila Scorticati

Introduction

Camila Scorticati is a distinguished inventor located in Ciudad Autónoma de Buenos Aires, Argentina. She is recognized for her breakthrough in the field of biomedicine, particularly for her work on modified human erythropoietin. With a unique approach to enhancing therapeutic outcomes, Scorticati's invention showcases her commitment to advancing medical science.

Latest Patents

Scorticati holds one patent which focuses on a modified version of human erythropoietin. This innovative creation has an increased plasma half-life while exhibiting an erythropoietic activity of less than 0.5% compared to native erythropoietin. Interestingly, her invention maintains neuroprotective and neuroplastic capabilities by incorporating mutations in at least one binding site of the homodimeric or heterodimeric receptor, alongside consensus sites for N-glycosylation.

Career Highlights

Throughout her career, Camila has been involved with prominent research institutions such as Universidad Nacional del Litoral and the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Her work has significantly contributed to the understanding and development of erythropoietin therapies, underscoring the importance of her research in the wider scientific community.

Collaborations

Camila Scorticati has collaborated with notable colleagues, including Marcos Oggero-Eberhardt and María de los Milagros Burgi-Fissolo. Their collective efforts have further advanced research in the biomedicine field, illustrating the power of teamwork in driving innovation and progress.

Conclusion

As a pioneering inventor, Camila Scorticati exemplifies the spirit of innovation in the scientific community. Her contributions to the development of modified human erythropoietin not only push the boundaries of medical research but also have the potential to improve patient outcomes in significant ways. Her ongoing work promises to inspire future advancements in the field of biomedicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…